NovoSanis

NovoSanis


Back


About Novosanis
Novosanis is a subsidiary of OraSure Technologies, Inc. Colli-Pee®, the heart of the company, allows volumetric and standardized first-void urine collection. The platform consists of variants capturing a range of urine volumes for different application purposes.

Why use first-void urine
First-void urine, generally termed the first 5mL to 50mL of urine flow, contains higher concentrations of STI-related DNA than other fractions. Additionally, first-void urine is important to identify prostate cancer biomarkers.

Why use Colli-Pee
Collecting a first-void urine sample with a standard urine cup can be awkward, messy and inconvenient for the user.
For this reason, Novosanis developed Colli-Pee®, a device that can be used by both men and women. Colli-Pee® allows for standardized, volumetric collection of the first fraction of urine. The device architecture also enables immediate mixing of urine and preservative for adequate stability.

To know more about the Colli-Pee device visit https://novosanis.com/our-products






Back